unilateral inguinal hernia
Conditions
Interventions
experimental group:Liposomal bupivacaine of different concentrations for ultrasound-guided posterior quadratus lumborum block
Sponsors
The First Hospital Of Jiaxing
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. ASA physical status classification I to III; 2. Age ranging from 18 to 85 years old; 3. Body mass index (BMI) between 18 and 30 kg/m^2; 4. The patient or authorized legal representative has signed the surgical and anesthesia informed consent form, fully understands the trial content, voluntarily participates in this study, and signs the trial-specific informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with a history of local anesthetic allergy; 2.Patients with psychiatric or neurological disorders; 3.Severe cardiac,pulmonary,hepatic or renal dysfunction; 4.Patients with contraindications or complications of quadratus lumborum block,such as puncture site infection and coagulation disorders; 5.Patients with a history of chronic pain or preoperative use of sedatives or analgesics; 6.Patients refusing to participate in the trial;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MEC90 for successful pain relief within 36 hours after posterior lumbar quadratus lumborum block; | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS score; | — |
Countries
China
Contacts
Public ContactShen Zhangtian
The First Hospital Of Jiaxing
Outcome results
None listed